| Name | Isopropyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-glucopyranoside |
|---|---|
| Synonyms |
T4 IN C34,Toll-like Rector (T,Inhibitor,T4INC34,inhibit,T-4-IN-C34
ISOPROPYL 2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSIDE 3,4,6-TRIACETATE α-D-Glucopyranoside, 1-methylethyl 2-(acetylamino)-2-deoxy-, 3,4,6-triacetate C34 1-Methylethyl 2-(acetylamino)-2-deoxy-a-Dglucopyranoside 3,4,6-triacetate T4-IN-C34 ,S0822 Isopropyl 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-glucopyranoside, Min T4-IN-C34, 10 mM in DMSO Isopropyl 2-(acetylamino)-2-deoxy á-D-glucopyranoside 3,4,6-triacetate MFCD28053519 2-Acetamidopyranoside (2R,3S,4R,5R,6S)-5-Acetamido-2-(acetoxymethyl)-6-isopropoxytetrahydro-2H-pyran-3,4-diyl diacetate T4-IN-C34 1-Methylethyl 2-(acetylamino)-2-deoxy-α-D-glucopyranoside 3,4,6-triacetate Isopropyl 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-glucopyranoside T4-C34 |
| Description | TLR4-IN-C34 is an orally active TLR4 inhibitor and reduces systemic inflammation in models of endotoxemia and necrotizing enterocolitis[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | TLR4-IN-C34 (C34, 1 mg/kg, orally daily) could attenuate NEC severity and demonstrates a marked preservation of the intestinal mucosa[1]. Animal Model: Experimental NEC induced in 7-8 day old mice[1]. Dosage: 1 mg/kg. Administration: Orally every morning. Result: Attenuated intestinal inflammation. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 519.8±50.0 °C at 760 mmHg |
| Molecular Formula | C17H27NO9 |
| Molecular Weight | 389.398 |
| Flash Point | 268.2±30.1 °C |
| Exact Mass | 389.168579 |
| LogP | 0.83 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.484 |
| RIDADR | NONH for all modes of transport |
|---|